Suntrust Banks’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Suntrust Banks’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,881	Closed	-$372K	–	1367
2017 Q4	$372K	Buy	6,881 +561	+9%	+$30.7K	﹤0.01%	968
2017 Q3	$361K	Sell	6,320 -288	-4%	-$16.9K	﹤0.01%	981
2017 Q2	$397K	Sell	6,608 -582	-8%	-$33.1K	﹤0.01%	934
2017 Q1	$391K	Buy	+7,190	New	+$354K	﹤0.01%	914

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Suntrust Banks's BIVV Position: Q1 2018 in Review

Suntrust Banks sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 6,881 shares — an estimated $372K sold.

Suntrust Banks first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $397K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Suntrust Banks reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Suntrust Banks sold 6,881 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $372K.
Suntrust Banks first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Suntrust Banks's Bioverativ Inc. Common Stock position peaked at $397K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Suntrust Banks's 13F filing for Q1 2018, filed 14 May 2018.